Clinical experience with desmopressin: Efficacy and safety in central diabetes insipidus and other conditions
- 30 April 1989
- journal article
- review article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 114 (4), 711-718
- https://doi.org/10.1016/s0022-3476(89)80886-8
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Central diabetes insipidus in children.Acta Endocrinologica, 1987
- Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: Reduction in blood product usage with desmopressinJournal of the American College of Cardiology, 1987
- Intranasal Administration of Peptides: Nasal Deposition, Biological Response, and Absorption of DesmopressinJournal of Pharmaceutical Sciences, 1986
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986
- Drugs Five Years Later: DesmopressinAnnals of Internal Medicine, 1985
- DESMOPRESSIN AS A TREATMENT FOR ENURESISThe Lancet, 1977
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975
- DDAVP test for estimation of renal concentrating capacity in infants and childrenArchives of Disease in Childhood, 1974
- EFFECTS OF DDAVP, A SYNTHETIC ANALOGUE OF VASOPRESSIN, IN PATIENTS WITH CRANIAL DIABETES INSIPIDUSActa Medica Scandinavica, 1972
- Amino acids and peptides. LXXI. Synthesis of 1-deamino-8-D-γ-aminobutyrine-vasopressin, 1-deamino-8-D-lysine-vasopressin, and 1-deamino-8-D-arginine-vasopressinCollection of Czechoslovak Chemical Communications, 1967